| Name | spiro[1,2-dihydroindene-3,4'-piperidine] |
|---|---|
| Synonyms |
spiroindane
Spiro[1H-indene-1,4'-piperidine], 2,3-dihydro- 2,3-Dihydrospiro[indene-1,4'-piperidine] |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 304.8±31.0 °C at 760 mmHg |
| Molecular Formula | C13H17N |
| Molecular Weight | 187.281 |
| Flash Point | 144.1±20.3 °C |
| Exact Mass | 187.136093 |
| PSA | 12.03000 |
| LogP | 3.07 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.585 |
| HS Code | 2933399090 |
|---|
|
~%
428-38-6 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2007/38459 A2, 2007 ; Location in patent: Page/Page column 72 ; |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |